These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20466687)

  • 21. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.
    Sandeman SR; Howell CA; Phillips GJ; Zheng Y; Standen G; Pletzenauer R; Davenport A; Basnayake K; Boyd O; Holt S; Mikhalovsky SV
    J Mater Sci Mater Med; 2014 Jun; 25(6):1589-97. PubMed ID: 24573455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
    Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.
    Pham NM; Recht NS; Hostetter TH; Meyer TW
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):85-90. PubMed ID: 18045861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of protein-bound uraemic solutes during predilution haemofiltration.
    Meert N; Beerenhout C; Schepers E; Glorieux G; Kooman J; Vanholder R
    J Nephrol; 2009; 22(3):352-7. PubMed ID: 19557711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro.
    Tsujimoto M; Higuchi K; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Otagiri M; Hirata S; Takara K; Nishiguchi K
    J Pharm Pharmacol; 2010 Jan; 62(1):133-8. PubMed ID: 20723009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on protein-bound uremic retention solutes.
    Vanholder R; Schepers E; Pletinck A; Neirynck N; Glorieux G
    J Ren Nutr; 2012 Jan; 22(1):90-4. PubMed ID: 22200422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.
    Chiu YL; Chen HY; Chuang YF; Hsu SP; Lai CF; Pai MF; Yang SY; Peng YS
    Nephrol Dial Transplant; 2008 Nov; 23(11):3685-9. PubMed ID: 18515654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
    Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
    Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients.
    Agatsuma S; Sekino H; Watanabe H
    Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis.
    Takayama F; Taki K; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S142-5. PubMed ID: 12612972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay.
    Calaf R; Cerini C; Génovésio C; Verhaeghe P; Jourde-Chiche N; Bergé-Lefranc D; Gondouin B; Dou L; Morange S; Argilés A; Rathelot P; Dignat-George F; Brunet P; Charpiot P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2281-6. PubMed ID: 21727042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
    Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Peteiro J; García-Naveiro R; García-Buela J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
    Dursun E; Dursun B; Süleymanlar G; Ozben T
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in rats.
    Deguchi T; Nakamura M; Tsutsumi Y; Suenaga A; Otagiri M
    Biopharm Drug Dispos; 2003 Nov; 24(8):345-55. PubMed ID: 14595703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease.
    Liabeuf S; Barreto DV; Barreto FC; Meert N; Glorieux G; Schepers E; Temmar M; Choukroun G; Vanholder R; Massy ZA;
    Nephrol Dial Transplant; 2010 Apr; 25(4):1183-91. PubMed ID: 19914995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in C-reactive protein during a single haemodialysis session do not associate with mortality.
    Meuwese CL; Halbesma N; Stenvinkel P; Dekker FW; Molanaei H; Qureshi AR; Barany P; Heimburger O; Lindholm B; Krediet RT; Boeschoten EW; Carrero JJ
    Nephrol Dial Transplant; 2010 Nov; 25(11):3717-23. PubMed ID: 20484301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.